% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/dat.Dupilumab.R
\docType{data}
\name{dat.Dupilumab}
\alias{dat.Dupilumab}
\title{A phase II trial of dupilumab investigating the treatment of atopic dermatitics}
\format{A data frame with following coloumns
\describe{
  \item{subgroup}{Subgroup (dose regimen) indicator for each patient. 1 is weekly, 2 is biweekly,
  and 3 is monthly dose regimen.}
  \item{frequency}{Frequency of administration in hours for each patient.}
  \item{dose}{Dosing amount for each patient}
  \item{resp}{Percentage change from baseline in EASI score}
}}
\source{
Thaci D, Simpson EL, Beck LA, et al. Efficacy and safety of dupilumab in adults with
 moderate-to-severe atopic dermatitis inadequately controlled by topical treatments:
 a randomised, placebo controlled, dose-ranging phase 2b trial. The Lancet. 2016;387:40â€“52.
}
\usage{
dat.Dupilumab
}
\description{
A dataset containing the results from a Phase II trial with multiple dose regimens
examining the efficacy of dupilumab against the atopic dermatitis.
(ClinicalTrials.gov identifier: NCT01859988).
}
\keyword{datasets}
